Results 251 to 260 of about 6,863,547 (308)

The Role of the Gut Microbiome in the Relationship Between the Mediterranean Diet and Cardiovascular Disease Risk. [PDF]

Curr Atheroscler Rep
Hernández-Cacho A, Ni J, García-Gavilán JF, Pérez-Acosta JA, Vázquez-Lorente H, Plaza-Diaz J, Salas-Salvadó J.   +6 more
europepmc   +1 more source

ZER1 Restrains Pressure Overload‐Induced Cardiac Remodeling by Targeting DVL2 for Gly/N‐Degron‐Dependent Degradation

Advanced Science, EarlyView.
Pressure overload suppresses cardiomyocyte ZER1, weakening CRL2Zer1‐mediated DVL2 degradation and allowing DVL2 accumulation. Elevated DVL2 activates CaMKII‐HDAC4‐MEF2C signaling, drives fetal gene reactivation, and promotes pathological remodeling.
Mingchao Jiang, Zhehao Lin, Lu Chen, Ying Ni, Jun Zhou, Wenjuan Zhang, Huilin Wang, Peifeng Ying, Xiu Lu, Kai Wang, Qingran Kong, Naxin Xu, Dingsheng Zhao, Jianwei Li, Guohui Zhong, Xingchen Meng, Sarkawt Hamad, Junmeng Zheng, Yuan Fu, Rongjiang Qin, Xuran Chu, Shangxuan Li, Youyou Li, Yili Wu, Yi Wang, Weihong Song, Yingxian Li, Shukuan Ling   +27 more
wiley   +1 more source

Beyond Traditional Risk Factors: The MAINER Approach to Atherosclerotic Cardiovascular Disease. [PDF]

Balkan Med J
Kaya Ç, Kardaş F, Tezer M.
europepmc   +1 more source

A Pathology‐Instructed Theranostic Platform with Mechanoadaptive and ROS‐Powered Nanobreathing Functions for Precision Myocardial Repair

Advanced Science, EarlyView.
We developed a pH responsive theranostic serum albumin hydrogel named BST, functionalized with MRI and CT probes and loaded with mitochondria targeted CAT‐SOD nanogels, that rapidly self repairs and mechanically stabilizes the infarcted myocardium, releases therapeutic nanogels and albumin under hypoxia induced acidosis to clear mitochondrial ROS ...
Zheng Luo, Cui Yang, Liuzhou Mao, Panqin Ma, Chiyu Jia, Karen Yuanting Tang, Xian Jun Loh, Yun‐Long Wu   +7 more
wiley   +1 more source

Dietary and Lifestyle Changes Before and After Diagnosis of Cardiovascular Disease. [PDF]

J Hum Nutr Diet
Suzuki A, Ishii Y, Takachi R, Ishihara J, Yamagishi K, Kokubo Y, Saito I, Yatsuya H, Muraki I, Iso H, Tsugane S, Sawada N.   +11 more
europepmc   +1 more source

Cost-Effectiveness of Pharmacogenomics-Guided Treatment in Cardiovascular Disease: An Umbrella Review. [PDF]

Pharmgenomics Pers Med
Janković SM, Milosavljević M, Stević I, Ašić A, Jusić A, Devaux Y, Belančić A, Bektay MY, Pejčić AV.   +8 more
europepmc   +1 more source

Lipoprotein(a) in cardiovascular disease: pathophysiology, residual risk, and emerging therapeutic strategies. [PDF]

Front Med (Lausanne)
Granata LG, Giubilato S, Campanella F, Amico F, Di Fusco SA, Colivicchi F.   +5 more
europepmc   +1 more source

Cardiovascular Disease Screening Programs in Low- and Middle-Income Countries: A Systematic Review. [PDF]

JACC Adv
Jamileh E, Elmewafy AT, Almeer M, Alaguraja P, Al-Kindi S, Dakhil Z, Alasnag M, Al Suwaidi J, Refaat MM, Taha MB, Hosseini K, Al Mahmeed W, Abdin A, Zakkar M, Antoun I.   +14 more
europepmc   +1 more source

Mechanism of Ferroptosis in Cardiovascular Disease and Its Regulation by Natural Compounds: A Narrative Review. [PDF]

Drug Des Devel Ther
Pan R, Koo C, Sun S, Liu B, Ye X.
europepmc   +1 more source